1. Cost-effectiveness of ticagrelor in patients with type 2 diabetes and coronary artery disease with a history of PCI: an economic evaluation of THEMIS-PCI using a Swedish healthcare perpective. (25th November 2020) Authors: Steg, P; Bhatt, D.L; James, S.K; Darlington, O; Hoskin, L; Simon, T; Fox, K; Leiter, L.A; Mehta, S; Harrington, R.A; Himmelmann, A; Ridderstrale, W; Andersson, M; Mellstrom, C; Mcewan, P Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗